Vitamin B12 immunization assay method and reagent thereof
A technology of reagents and preservatives, applied in the field of medical immunology in vitro diagnosis, to achieve the effect of improving practicability, improving specific recognition ability and high immunogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1: Synthesis and structure confirmation of VB12 derivatives
[0037] The biochemical structures of the VB12 derivatives used in the following examples are as follows: figure 1 Shown:
[0038] The specific synthetic steps of this VB12 derivative are as follows: figure 2 Shown:
[0039] 1) Weigh 23.7mg of VB12 and 22mg of succinic anhydride, add 3.0mL of anhydrous pyridine, reflux at 80°C for 2h, remove pyridine by rotary evaporation, add 4mL of ultrapure water, extract with 5mL×4 ethyl acetate, combine the organic phases, and subtract Press and spin dry to obtain a light red solid, namely the VB12 derivative (Formula 4).
[0040] Structural identification of the above light red solid purified product
[0041] 1) The obtained derivatives were analyzed and identified by chromatography / mass spectrometry (LCMS). Agilent's tandem quadrupole mass spectrometer LC / MSD1200 series was used, and the ion source was in positive or negative ionization mode. The chromatog...
Embodiment 2
[0043] Example 2: RSA-VB12 immunogen synthesis
[0044] The RSA-VB12 immunogen is composed of rabbit protein RSA and -CO-(CH 2 )n-COO-group connected, in the present embodiment, take n=2 as an example to describe the synthetic method of this immunogen in detail, and concrete steps are as follows:
[0045] 1) Dissolve 60mg of RSA in 6ml of 0.1M PBS with pH8.3, and place the above solution in beaker A;
[0046] 2) Mix 50mg of VB12 derivatives, 0.6ml of dimethylamide DMF, 0.5ml of ethanol, 1ml of 10mM MES buffer at pH5.0, 68mg of 1-ethyl-3-(-3-dimethylaminopropyl) The imine and 22 mg of N-hydroxysulfosuccinimide were dissolved in beaker B, and the reaction was stirred at room temperature for 1 hour.
[0047] 3) Slowly add the solution in beaker B to beaker A dropwise to obtain a mixed solution, and stir overnight at 2-8°C; dialyze and purify the above stirred mixed solution with neutral PBS buffer to obtain RSA-VB12 immune Original, stored at -70°C.
[0048] Similarly, when n...
Embodiment 3
[0050] Embodiment three: the preparation of anti-VB12 specific antibody
[0051] The RSA-VB12 immunogen that above-mentioned makes adopts conventional method to immunize New Zealand white rabbit, and after strengthening immunization, antiserum is taken, and concrete steps are as follows:
[0052] The RSA-VB12 immunogen synthesized above was diluted to 2.0 mg / ml with PBS to obtain an antigen solution, and then 1.0 ml of the antigen solution was mixed with Freund's complete adjuvant to subcutaneously immunize the back of New Zealand white rabbits at multiple points.
[0053] After 2 to 3 weeks, the New Zealand white rabbits were immunized once with 1.0 ml of the same antigen solution and Freund's incomplete adjuvant, and then immunized every three weeks for a total of 4 immunizations.
[0054] Blood was collected from the above New Zealand white rabbits, and the anti-VB12 specific antibody was obtained by separation and purification.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com